Workflow
GRAMMY® AWARD-WINNING, MULTIPLATINUM GLOBAL SUPERSTAR TYLA TO HOST NICKELODEON KIDS' CHOICE AWARDS 2025--THE BIGGEST PARTY OF THE SUMMER --LIVE ON SATURDAY, JUNE 21, AT 8 P.M. (ET/PT)
Prnewswire· 2025-05-15 21:06
Benson Boone, Jack Black, Ariana Grande, Cynthia Erivo, Chris Evans, Selena Gomez, Jalen Hurts, Travis Kelce, Kendrick Lamar, Peyton List, Jason Momoa, MrBeast, Jenna Ortega, Keanu Reeves, Taylor Swift, Charli XCX and More, Announced as KCA NomineesShare It: @Nickelodeon @KidsChoiceAwards #KCAClick HERE to download photos and HERE to embed video.HOLLYWOOD, Calif., May 15, 2025 /PRNewswire/ -- Grammy® Award-winning, multiplatinum global superstar Tyla is set to take the Slime-tastic stage as host of the bigg ...
AMD: Something Bigger Than The $6B Buyback Comes Next Month
Seeking Alpha· 2025-05-15 21:05
全球贸易与芯片出口限制 - 近期全球贸易和芯片出口限制的不确定性持续近两个月后首次出现曙光[1] 分析师背景 - 分析师专注于科技行业研究 重点覆盖半导体 人工智能和云计算软件领域[2] - 研究范围延伸至医疗科技 国防科技和可再生能源等其他领域[2] - 分析师曾在硅谷领导苹果和谷歌等全球顶级科技公司的团队[2] 研究影响力 - 分析师与妻子共同撰写的通讯被华尔街日报 福布斯等主流媒体频繁引用[2]
Abbott's Libre® Technology is First Continuous Glucose Monitor Associated with Reduced Hospitalizations for Heart Complications in People with Diabetes
Prnewswire· 2025-05-15 21:05
New data reveal a 78% reduction in cardiovascular disease-related hospitalizations for people living with Type 1 diabetes with prior severe low blood sugar episodes.1 This significant decrease is linked to the use of Libre biowearable technology compared to traditional blood glucose monitors.1 Results also show a reduction in hospitalization for cardiovascular complications in adults with Type 2 diabetes on insulin using Libre technology.2 ABBOTT PARK, Ill., May 15, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) ...
Supermicro's Revolutionary Data Center Building Block Solutions® (DCBBS) Simplify and Shorten Global-Scale Buildouts of AI/IT Liquid-Cooled Data Centers
Prnewswire· 2025-05-15 21:05
Easy-to-design, easy-to-build, easy-to-deploy, and easy-to-operate solution for all critical computing and cooling infrastructure Quick time-to-deployment and quick time-to-online with everything required to fully outfit AI/IT data centers Saving cost with modularized building block solution architecture from system to rack to data center scale High quality and high availability with Supermicro's industry-leading design, manufacturing capacity, management software, on-site services, and global support SAN ...
National HealthCare Is A Buy After Strong First Quarter Results
Seeking Alpha· 2025-05-15 20:57
Editor's note: Seeking Alpha is proud to welcome James O'Grady as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access.I practiced in a medical field for 12 years before achieving financial independence in 2017. I focus on researching under the radar companies that get little analyst coverage. I am primarily interested in finding opportunities in defensive se ...
Best Income Stocks to Buy for May 15th
ZACKS· 2025-05-15 20:55
Here are three stocks with buy rank and strong income characteristics for investors to consider today, May 15th:Usinas Siderurgicas de Minas Gerais (USNZY) : This company which is Latin America's biggest flat steel complex and it ranks among the world's largest twenty steel producers, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 50% over the last 60 days.This Zacks Rank #1 (Strong Buy) company has a dividend yield of 4.7%, compared with the industry average of 1.7%.Ban ...
GSK Inks $2B Deal With Boston Pharmaceuticals to Buy Liver Disease Drug
ZACKS· 2025-05-15 20:55
GSK plc (GSK) announced that it has signed an agreement with Massachusetts-based biopharmaceutical company Boston Pharmaceuticals to acquire the latter’s lead pipeline drug, efimosfermin alfa.Efimosfermin is an investigational long-acting variant of FGF21 protein designed to treat and prevent the progression of steatotic liver disease (SLD), commonly known as fatty liver disease. Boston Pharma is currently evaluating the drug in mid-stage studies for metabolic dysfunction-associated steatohepatitis (MASH), ...
Is Axon Stock Too Expensive—or Just Getting Started?
MarketBeat· 2025-05-15 20:53
For security and defense company Axon Enterprise NASDAQ: AXON, Q1 earnings were exactly what it needed to take its 2025 returns from decent to delightful. Axon Enterprise TodayAXONAxon Enterprise$728.53 +3.76 (+0.52%) 52-Week Range$273.52▼$732.17P/E Ratio188.25Price Target$652.73Add to WatchlistThe company’s results massively impressed markets, leading to shares rising over 14% afterwards. The broadly positive effects of the United States and China trade deal also boosted Axon shares. Combining these moves ...
NASDAQ Index, SP500, Dow Jones Forecasts – US Indices Look Stretched
FX Empire· 2025-05-15 20:49
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...
Realty Income: Shareholders Deserve To Be Rewarded With More Upside
Seeking Alpha· 2025-05-15 20:47
With a market capitalization of $50.95 billion, Realty Income (NYSE: O ) is a giant in the REIT space. Over the years, the company has achieved remarkable growth, with acquisitions of other major players in the industry helping to makeCrude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential.Subscribers get to use a 50+ stock model account, in-depth cas ...